BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26561742)

  • 1. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS
    Bioorg Chem; 2016 Feb; 64():1-12. PubMed ID: 26561742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological screening of some novel celecoxib and etoricoxib analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Alsayed SS; Elshemy HA; Abdelgawad MA; Abdel-Latif MS; Abdellatif KR
    Bioorg Chem; 2017 Feb; 70():173-183. PubMed ID: 28057325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation.
    Bari SB; Firake SD
    Antiinflamm Antiallergy Agents Med Chem; 2016; 15(1):44-53. PubMed ID: 27216235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of novel triarylpyrazoline derivatives as selective COX-2 inhibitors.
    Abdellatif KR; Abdelgawad MA; Labib MB; Zidan TH
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5787-91. PubMed ID: 26546221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidine derivatives bearing thiazolidinone moiety as anti-inflammatory agents.
    Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM
    Bioorg Chem; 2018 Oct; 80():164-173. PubMed ID: 29929077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
    Firke SD; Bari SB
    Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a COX-2 selective inhibitor hit with anti-inflammatory activity and gastric ulcer protective effect.
    Abdelgawad MA; Bakr RB; El-Gendy AO; Kamel GM; Azouz AA; Bukhari SNA
    Future Med Chem; 2017 Oct; 9(16):1899-1912. PubMed ID: 29076755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel 4- Aryl-2(1H)-phthalazinone Derivatives as Cyclooxygenase-2 Inhibitors: Synthesis, Molecular Modeling Study and Evaluation as Promising Anti-inflammatory Agents.
    Hasabelnaby S; Mohi El-Deen EM; Goudah A
    Antiinflamm Antiallergy Agents Med Chem; 2015; 14(3):148-63. PubMed ID: 26526600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,3,5-triarylpyrazoline and 1,5-diarylpyrazole derivatives as selective COX-2 inhibitors.
    Abdellatif KRA; Abdelall EKA; Fadaly WAA; Kamel GM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):406-412. PubMed ID: 26691756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitors.
    Khan A; Diwan A; Thabet HK; Imran M
    Drug Dev Res; 2020 Aug; 81(5):573-584. PubMed ID: 32173897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-acidic 1,3,4-trisubstituted-pyrazole derivatives as lonazolac analogs with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
    Abdellatif KRA; Fadaly WAA; Elshaier YAMM; Ali WAM; Kamel GM
    Bioorg Chem; 2018 Apr; 77():568-578. PubMed ID: 29475165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on celecoxib scaffold supported with in vivo anti-inflammatory activity, ulcerogenic liability, ADME profiling and docking study.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2022 Mar; 120():105627. PubMed ID: 35065465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
    Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
    Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Coumarin Derivatives as Potent Selective COX-2 Inhibitors: Synthesis, Anti-Inflammatory, QSAR, and Molecular Modeling Studies.
    Dawood DH; Batran RZ; Farghaly TA; Khedr MA; Abdulla MM
    Arch Pharm (Weinheim); 2015 Dec; 348(12):875-88. PubMed ID: 26462142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
    Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
    J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.